A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Single and Multiple Oral Dose of TAK-418 in Healthy Female Participants
Clinical trial NCT03501069 · TERMINATED
Trial details
- NCT number
- NCT03501069
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-30
- Primary completion
- 2018-12-26
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.